Characterization of the cellular origin of a tissue-engineered human phalanx model by in situ hybridization

Tissue Engineering

Volumn 10, Issue 7-8, 2004, Pages 1204-1213

  Chubinskaya, Susan ^a   Jacquet, Robin ^b   Isogai, Noritaka ^c   Asamura, Shinichi ^c   Landis, William J ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Northeastern Ohio Medical University   (United States)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BIGLYCAN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; DECORIN; OLIGONUCLEOTIDE; OSTEOPONTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; SIALOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BONE DEVELOPMENT; CARTILAGE TRANSPLANTATION; CATTLE; CELL TYPE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENE SEQUENCE; IMPLANT; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OLIGONUCLEOTIDE PROBE; OSTEOBLAST; PERIOSTEUM TRANSPLANTATION; PHALANX; PRIORITY JOURNAL; SPECIES DIFFERENCE; TENDON TRANSPLANTATION; TIME SERIES ANALYSIS; TISSUE ENGINEERING; TISSUE SPECIFICITY;

ANIMALS; BIOARTIFICIAL ORGANS; CHONDROCYTES; FINGERS; GENE EXPRESSION PROFILING; HUMANS; IMPLANTS, EXPERIMENTAL; IN SITU HYBRIDIZATION; MICE; MICE, NUDE; MODELS, ANIMAL; OSTEOBLASTS; SWINE; TISSUE ENGINEERING;

EID: 4544276996     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2004.10.1204     Document Type: Article

References (15)

1. Isogai, N., Landis, W., Kim, T.H., Gerstenfeld, L.C., Upton, J., and Vacanti, J.P. Formation of phalanges and small joints by tissue-engineering. J. Bone Joint Surg. Am. 81, 306, 1999.
2. Chubinskaya, S., Huch, K., Mikecz, K., Cs-Szabo, G., Hasty, K.A., Kuettner, K.E., and Cole, A.A. Chondrocyte MMP: Up-regulation of neutrophil collagenase by interleukin-1β in human cartilage from knee and ankle joints. Lab. Invest. 74, 232, 1996.
3. Sandell, L.J., Morris, N., Robbins, J.R., and Goldring, M.B. Alternatively spliced type II procollagen mRNAs define distinct populations of cells during vertebral development: Differential expression of the amino-propeptide. J. Cell Biol. 114, 1307, 1991.
4. Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council. Guide for the Care and Use of Laboratory Animals. Publication 85-23, revised 1985. Washington, D.C.: United States Department of Health, Education, and Welfare, National Institutes of Health, 1985.
5. Rosenberg, L. Chemical basis for the histological use of safranin-O in the study of articular cartilage. J. Bone Joint Surg. Am. 53, 69, 1971.
6. Aydelotte, M.B., Mok, S.S., Michal, L., and Häuselmann, H.J. Effects of misoprostol with interleukin-1 on proteoglycan metabolism of cultured articular chondrocytes. Am. J. Ther. 3, 3, 1996.
7. Aydelotte, M.B., Schumacher, B.L., and Kuettner, K.E. Heterogeneity of articular chondrocytes. In: Kuettner, K.E., Schleyerbach, R., Peyron, J.G., and Hascall, V.C., eds. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1991, pp. 237-250.
8. Hunziker, E.B. Articular cartilage structure in humans and experimental animals. In: Kuettner, K.E., Schleyerbach, R., Peyron, J.G., and Hascall, V.C., eds. Articular Cartilage and Osteoarthritis. New York: Raven Press, 1991, pp. 183-200.
9. Kinsella, M.G., Fischer, J.W., Mason, D.P., and Wight, T.N. Retrovirally mediated expression of decorin by macrovascular endothelial cells. J. Biol. Chem. 275, 13924, 2000.
10. Schmid, T.M., Bonen, D.K., Luchene, L., and Linsenmayer, T.F. Late events in chondrocyte differentiation: Hypertrophy, type X collagen synthesis and matrix calcification. In Vivo 5, 533, 1991.
11. McKee, M.D., and Nanci, A. Ultrastructural, cytochemical and immunocytochemical studies on bone and its interfaces. Cells Mater. 3, 219, 1993.
12. Yanke, A., Hillyer, J., Killius, J., Isogai, N., Asamura, S., Jacquet, R., and Landis, W. Vascularity of a tissue-engineered model of human phalanges. Microsc. Microanal. 8, 1024CD, 2002.
13. Breier, G., and Risau, W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol. 6, 454, 1996.
14. Klagsbrun, M., and D'Amore, P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev. 7, 259, 1996.
15. Tsou, R., Fathke, C., Wilson, L., Wallace, K., Gibran, N., and Isik, F. Retroviral delivery of dominant-negative vascular endothelial growth factor receptor type 2 to murine wounds inhibit wound angiogenesis. Wound Repair Regen. 10, 222, 2002.